Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
6
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
medicare
drug prices
fda
pfizer
president trump
regeneron pharmaceuticals
abbvie
alexion pharmaceuticals
alzheimer's disease
astrazeneca
biogen
bristol-myers squibb
cancer
What
drug
prices
6
×
bio
long
lower
plan
roundup
alzheimer’s
awaited
details
drugs
gene
house
pharmaceutical
prescription
afternoon
anathema
annual
anticipated
aren’t
assessed
attention
away
biotech
blueprint
bringing
ceos
communities
companies
conference
cost
cut
dc
democrat
developers
different
elements
esmo
europe
executives
Language
unset
Current search:
" raleigh-durham blog main "
×
prices
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details